{"id":48426,"date":"2025-11-17T13:41:00","date_gmt":"2025-11-17T05:41:00","guid":{"rendered":"https:\/\/flcube.com\/?p=48426"},"modified":"2025-11-17T13:41:01","modified_gmt":"2025-11-17T05:41:01","slug":"westvac-biopharma-west-china-hospital-secure-nmpa-clearance-for-chinas-first-acne-therapeutic-vaccine","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=48426","title":{"rendered":"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine"},"content":{"rendered":"\n<p><strong>WestVac BioPharma Co., Ltd.<\/strong>  announced that the <strong>National Medical Products Administration (NMPA)<\/strong> has granted <strong>clinical\u2011trial approval<\/strong> for its <strong>acne therapeutic vaccine<\/strong>, co\u2011developed with <strong>West China Hospital of Sichuan University<\/strong>. The vaccine is the <strong>first acne\u2011targeted immunotherapy to reach the clinical stage in China<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Agency<\/strong><\/td><td>NMPA (China)<\/td><\/tr><tr><td><strong>Decision<\/strong><\/td><td>Approval to commence Phase\u202fI clinical trials<\/td><\/tr><tr><td><strong>Date Issued<\/strong><\/td><td>12\u202fNov\u202f2025<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>Recombinant protein acne therapeutic vaccine<\/td><\/tr><tr><td><strong>Partners<\/strong><\/td><td>WestVac BioPharma &amp; West China Hospital, Sichuan University<\/td><\/tr><tr><td><strong>Next Milestone<\/strong><\/td><td>Initiate first\u2011in\u2011human dosing by Q1\u202f2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-vaccine-profile-amp-technology\">Vaccine Profile &amp; Technology<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Platform:<\/strong> Genetically engineered recombinant protein expressed in <em>E.\u202fcoli<\/em> (or appropriate expression system).<\/li>\n\n\n\n<li><strong>Target Antigen:<\/strong> A virulence factor uniquely expressed by the pathogenic <em>Cutibacterium acnes<\/em> (formerly <em>Propionibacterium acnes<\/em>) strain.<\/li>\n\n\n\n<li><strong>Design Highlights:<\/strong><\/li>\n\n\n\n<li><strong>Optimized protein structure<\/strong> to minimize toxicity while preserving strong antigenicity.<\/li>\n\n\n\n<li><strong>Single\u2011dose regimen<\/strong> intended to elicit durable immune protection.<\/li>\n\n\n\n<li><strong>Microbiome\u2011sparing:<\/strong> Precisely attacks the pathogenic subtype without disrupting commensal skin flora, preserving the skin\u2019s micro\u2011ecological balance.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-clinical-development-plan\">Clinical Development Plan<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Phase<\/th><th>Objective<\/th><th>Sample Size<\/th><th>Estimated Completion<\/th><\/tr><\/thead><tbody><tr><td><strong>Phase\u202fI<\/strong><\/td><td>Safety, tolerability, and immunogenicity in mild\u2011to\u2011moderate acne patients<\/td><td>30 subjects<\/td><td>Q4\u202f2026<\/td><\/tr><tr><td><strong>Phase\u202fII<\/strong> (planned)<\/td><td>Dose\u2011response, efficacy (lesion count reduction)<\/td><td>120 subjects<\/td><td>Q2\u202f2028<\/td><\/tr><tr><td><strong>Phase\u202fIII<\/strong> (future)<\/td><td>Pivotal efficacy &amp; long\u2011term safety across diverse ethnic groups<\/td><td>600+ subjects<\/td><td>2029\u201130<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-outlook\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Unmet Need:<\/strong> Acne affects >\u202f80\u202f% of adolescents and a sizable adult population worldwide; current therapies are topical or systemic antibiotics with resistance concerns.<\/li>\n\n\n\n<li><strong>Commercial Potential:<\/strong> Global acne treatment market \u2248\u202fUS$12\u202fbillion (2024). A <strong>first\u2011in\u2011class vaccine<\/strong> could capture a <strong>5\u201110\u202f% share<\/strong> within five years, translating to <strong>US$600\u20111,200\u202fmillion<\/strong> in annual sales.<\/li>\n\n\n\n<li><strong>Strategic Advantage:<\/strong><\/li>\n\n\n\n<li><strong>Microbiome\u2011preserving<\/strong> approach differentiates it from antibiotics and retinoids.<\/li>\n\n\n\n<li><strong>Single\u2011dose<\/strong> administration simplifies adherence and reduces healthcare\u2011system burden.<\/li>\n\n\n\n<li><strong>Funding Outlook:<\/strong> WestVac has earmarked <strong>RMB\u202f150\u202fmillion<\/strong> (~US$22\u202fmillion) for Phase\u202fI\u2011II activities, with additional financing under discussion with strategic partners and venture investors.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This brief contains forward\u2011looking statements regarding regulatory timelines, clinical development, and commercial expectations for the acne therapeutic vaccine. Actual results may differ due to risks including clinical trial outcomes, regulatory approvals, market acceptance, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial&#8230;<\/p>\n","protected":false},"author":1,"featured_media":48428,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[62,12,2817],"class_list":["post-48426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","tag-clinical-trial-approval-initiation","tag-vaccine","tag-westvac-biopharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial approval for its acne therapeutic vaccine, co\u2011developed with West China Hospital of Sichuan University. The vaccine is the first acne\u2011targeted immunotherapy to reach the clinical stage in China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=48426\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine\" \/>\n<meta property=\"og:description\" content=\"WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial approval for its acne therapeutic vaccine, co\u2011developed with West China Hospital of Sichuan University. The vaccine is the first acne\u2011targeted immunotherapy to reach the clinical stage in China.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=48426\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-17T05:41:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-17T05:41:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine\",\"datePublished\":\"2025-11-17T05:41:00+00:00\",\"dateModified\":\"2025-11-17T05:41:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426\"},\"wordCount\":368,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1703.webp\",\"keywords\":[\"Clinical trial approval \\\/ initiation\",\"Vaccine\",\"WestVac Biopharma\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=48426#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=48426\",\"name\":\"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1703.webp\",\"datePublished\":\"2025-11-17T05:41:00+00:00\",\"dateModified\":\"2025-11-17T05:41:01+00:00\",\"description\":\"WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial approval for its acne therapeutic vaccine, co\u2011developed with West China Hospital of Sichuan University. The vaccine is the first acne\u2011targeted immunotherapy to reach the clinical stage in China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=48426\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1703.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1703.webp\",\"width\":1080,\"height\":608,\"caption\":\"WestVac BioPharma & West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=48426#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine - Insight, China&#039;s Pharmaceutical Industry","description":"WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial approval for its acne therapeutic vaccine, co\u2011developed with West China Hospital of Sichuan University. The vaccine is the first acne\u2011targeted immunotherapy to reach the clinical stage in China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=48426","og_locale":"en_US","og_type":"article","og_title":"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine","og_description":"WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial approval for its acne therapeutic vaccine, co\u2011developed with West China Hospital of Sichuan University. The vaccine is the first acne\u2011targeted immunotherapy to reach the clinical stage in China.","og_url":"https:\/\/flcube.com\/?p=48426","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-17T05:41:00+00:00","article_modified_time":"2025-11-17T05:41:01+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=48426#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=48426"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine","datePublished":"2025-11-17T05:41:00+00:00","dateModified":"2025-11-17T05:41:01+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=48426"},"wordCount":368,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=48426#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp","keywords":["Clinical trial approval \/ initiation","Vaccine","WestVac Biopharma"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=48426#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=48426","url":"https:\/\/flcube.com\/?p=48426","name":"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=48426#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=48426#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp","datePublished":"2025-11-17T05:41:00+00:00","dateModified":"2025-11-17T05:41:01+00:00","description":"WestVac BioPharma Co., Ltd. announced that the National Medical Products Administration (NMPA) has granted clinical\u2011trial approval for its acne therapeutic vaccine, co\u2011developed with West China Hospital of Sichuan University. The vaccine is the first acne\u2011targeted immunotherapy to reach the clinical stage in China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=48426#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=48426"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=48426#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp","width":1080,"height":608,"caption":"WestVac BioPharma & West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=48426#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"WestVac BioPharma &amp; West China Hospital Secure NMPA Clearance for China\u2019s First Acne Therapeutic Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1703.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=48426"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48426\/revisions"}],"predecessor-version":[{"id":48429,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/48426\/revisions\/48429"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/48428"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=48426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=48426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=48426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}